African Bundibugyo ebolavirus vaccine candidate to be advanced to clinical trialsAugust 27, 2026 CEPI backs Minapharm’s Bundibugyo ebolavirus vaccine candidate, based on ProBioGen’s proprietary MVA-CR19 platform
